
TELO Valuation
Telomir Pharmaceuticals Inc
- Overview
- Forecast
- Valuation
- Earnings
TELO Relative Valuation
TELO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TELO is overvalued; if below, it's undervalued.
Historical Valuation
Telomir Pharmaceuticals Inc (TELO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.03. The fair price of Telomir Pharmaceuticals Inc (TELO) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:2.19
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-404.58
P/B
Median3y
54.61
Median5y
54.61
-5.86
FCF Yield
Median3y
-4.42
Median5y
-4.42
Competitors Valuation Multiple
The average P/S ratio for TELO's competitors is 3.08, providing a benchmark for relative valuation. Telomir Pharmaceuticals Inc Corp (TELO) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

QUIK
Quicklogic Corp
6.210
USD
-3.57%

MRAM
Everspin Technologies Inc
6.360
USD
-2.75%

CRBU
Caribou Biosciences Inc
2.280
USD
-3.80%

SKYX
SKYX Platforms Corp
1.140
USD
+2.70%

MMLP
Martin Midstream Partners LP
2.800
USD
0.00%

AISP
Airship AI Holdings Inc
5.670
USD
-0.70%

GGR
Gogoro Inc
0.393
USD
+3.69%

STIM
Neuronetics Inc
4.490
USD
+0.90%

LARK
Landmark Bancorp Inc
26.190
USD
+0.31%

UEIC
Universal Electronics Inc
6.310
USD
-1.10%
FAQ

Is Telomir Pharmaceuticals Inc (TELO) currently overvalued or undervalued?
Telomir Pharmaceuticals Inc (TELO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.03. The fair price of Telomir Pharmaceuticals Inc (TELO) is between to according to relative valuation methord.

What is Telomir Pharmaceuticals Inc (TELO) fair value?

How does TELO's valuation metrics compare to the industry average?

What is the current P/B ratio for Telomir Pharmaceuticals Inc (TELO) as of Jul 27 2025?

What is the current FCF Yield for Telomir Pharmaceuticals Inc (TELO) as of Jul 27 2025?

What is the current Forward P/E ratio for Telomir Pharmaceuticals Inc (TELO) as of Jul 27 2025?
